PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY
Clinical trial NCT06354140 · RECRUITING
Trial details
- NCT number
- NCT06354140
- Sponsor
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-07
- Primary completion
- 2027-05-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.